TOT BIOPHARM International Company Limited
HKEX:1875.HK
1.74 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 520.603 | 452.566 | 328.063 | 260.159 | 182.019 | 53.193 | 23.132 | 9.461 | 13.03 | 20.702 | 24.606 | 11.327 | 9.805 | 9.805 | 9.805 | 12.902 | 12.902 | 12.902 |
| Cost of Revenue
| 143.695 | 128.583 | 78.06 | 48.085 | 23.478 | 39.708 | 9.143 | 3.82 | 3.141 | 3.964 | 7.352 | 2.829 | 1.495 | 1.495 | 1.495 | 1.061 | 1.061 | 1.061 |
| Gross Profit
| 376.908 | 323.983 | 250.003 | 212.074 | 158.541 | 13.485 | 13.989 | 5.641 | 9.889 | 16.738 | 17.254 | 8.498 | 8.31 | 8.31 | 8.31 | 11.842 | 11.842 | 11.842 |
| Gross Profit Ratio
| 0.724 | 0.716 | 0.762 | 0.815 | 0.871 | 0.254 | 0.605 | 0.596 | 0.759 | 0.809 | 0.701 | 0.75 | 0.848 | 0.848 | 0.848 | 0.918 | 0.918 | 0.918 |
| Reseach & Development Expenses
| 46.059 | 53.921 | 49.969 | 80.9 | 70.268 | 125.95 | 88.749 | 135.871 | 99.325 | 115.274 | 75.804 | 47.77 | 47.163 | 47.163 | 47.163 | 26.484 | 26.484 | 26.484 |
| General & Administrative Expenses
| 32.105 | 37.206 | 31.104 | 36.889 | 25.698 | 29.513 | 26.823 | 22.737 | 24.118 | 60.036 | 35.055 | 23.773 | 7.802 | 7.802 | 7.802 | 2.293 | 2.293 | 2.293 |
| Selling & Marketing Expenses
| 276.482 | 243.643 | 197.376 | 133.863 | 70.091 | 11.647 | 11.202 | 12.227 | 13.726 | 14.696 | 16.848 | 7.886 | 9.734 | 9.734 | 9.734 | 7.222 | 7.222 | 7.222 |
| SG&A
| 308.587 | 280.531 | 228.48 | 171.349 | 95.789 | 41.16 | 38.025 | 34.964 | 37.844 | 74.732 | 51.903 | 31.659 | 17.536 | 17.536 | 17.536 | 9.515 | 9.515 | 9.515 |
| Other Expenses
| -10.996 | 8.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -79.137 | -79.137 | -64.664 | -64.664 | -64.664 | 2.431 | 2.431 | 2.431 |
| Operating Expenses
| 343.65 | 342.467 | 264.182 | 245.062 | 171.262 | 157.757 | 129.434 | 165.95 | 138.252 | 198.556 | 134.125 | 0.292 | 0.035 | 0.035 | 0.035 | 38.429 | 38.429 | 38.429 |
| Operating Income
| 33.258 | -18.484 | -14.576 | -31.983 | -6.948 | -140.012 | -115.445 | -163.064 | -128.363 | -160.52 | -110.977 | -67.874 | -59.152 | -59.152 | -59.152 | -26.588 | -26.588 | -26.588 |
| Operating Income Ratio
| 0.064 | -0.041 | -0.044 | -0.123 | -0.038 | -2.632 | -4.991 | -17.235 | -9.851 | -7.754 | -4.51 | -5.992 | -6.033 | -6.033 | -6.033 | -2.061 | -2.061 | -2.061 |
| Total Other Income Expenses Net
| -1.699 | -4.11 | -0.586 | -2.339 | -8.776 | -1.956 | 0.44 | 0.994 | -0.82 | -23.094 | -4.709 | -6.951 | -7.914 | -7.914 | -7.914 | -10.584 | -10.584 | -10.584 |
| Income Before Tax
| 31.559 | -22.594 | -15.162 | -34.322 | -15.724 | -146.211 | -115.005 | -159.315 | -129.183 | -183.614 | -115.686 | -74.825 | -67.066 | -67.066 | -67.066 | -37.172 | -37.172 | -37.172 |
| Income Before Tax Ratio
| 0.061 | -0.05 | -0.046 | -0.132 | -0.086 | -2.749 | -4.972 | -16.839 | -9.914 | -8.869 | -4.702 | -6.606 | -6.84 | -6.84 | -6.84 | -2.881 | -2.881 | -2.881 |
| Income Tax Expense
| 0 | 12.021 | 0.001 | 0.819 | 0 | 0 | 0 | 0 | 0 | 0 | -6.378 | -6.378 | -7.313 | -7.313 | -7.313 | -10.515 | -10.515 | -10.515 |
| Net Income
| 31.559 | -22.594 | -15.163 | -34.192 | -15.724 | -146.211 | -115.005 | -159.315 | -129.183 | -183.614 | -115.686 | -74.825 | -67.066 | -67.066 | -67.066 | -37.172 | -37.172 | -37.172 |
| Net Income Ratio
| 0.061 | -0.05 | -0.046 | -0.131 | -0.086 | -2.749 | -4.972 | -16.839 | -9.914 | -8.869 | -4.702 | -6.606 | -6.84 | -6.84 | -6.84 | -2.881 | -2.881 | -2.881 |
| EPS
| 0.044 | -0.031 | -0.021 | -0.049 | -0.027 | -0.25 | -0.2 | -0.28 | -0.23 | -0.49 | -0.39 | -0.22 | -0.12 | -0.12 | -0.12 | -0.065 | -0.065 | -0.065 |
| EPS Diluted
| 0.044 | -0.031 | -0.021 | -0.049 | -0.027 | -0.25 | -0.2 | -0.28 | -0.23 | -0.49 | -0.39 | -0.22 | -0.12 | -0.12 | -0.12 | -0.065 | -0.065 | -0.065 |
| EBITDA
| 61.76 | 15.752 | 2.007 | -14.492 | 10.064 | -123.688 | -100.516 | -148.412 | -114.101 | -148.204 | -99.136 | -67.415 | -62.551 | -62.551 | -62.551 | -33.729 | -33.729 | -33.729 |
| EBITDA Ratio
| 0.119 | 0.035 | 0.006 | -0.056 | 0.055 | -2.325 | -4.345 | -15.687 | -8.757 | -7.159 | -4.029 | -5.952 | -6.38 | -6.38 | -6.38 | -2.614 | -2.614 | -2.614 |